The purpose of this study is to evaluate the anti-emetic effect of oral ondansetron. For this evaluation, the investigators will perform a multi-center, double-blind, placebo-controled, randomized study. The investigators assumption is that oral ondansetron prior to intramuscular ketamine will reduce the occurrence of ketamine-induced vomiting.
Methods * a multi-center, double-blind, placebo-controled, randomized study ( 4 tertiary hospital ED) * survey for the occurrence of vomiting at ED and after discharge Primary outcome * the number of vomiting at ED and at home Secondary outcome * parent's satisfaction and ED length of stay
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
266
2mg (5mL) in \< 15 kg and 4mg (10mL) in 15kg to 30kg
Seoul National University Hospital
Seoul, South Korea
RECRUITINGvomiting at ED stay and 12 hours after discharge
Time frame: the participants will be followed for the duration of ED stay (upto 24hr) and 12hours after discharge
parent's satisfaction
Time frame: satisfaction will be surveyed within 48hours after discharge
length of emergency department stay
Time frame: length of stay will be calculated upto 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.